THERAPEUTIC TARGETING OF NUCLEAR HORMONE RECEPTORS IN NEUROFIBROMIN/NF1-DEPLETED BREAST CANCER

$768,000FY2021Defense Health AgencyDOD

Baylor College Of Medicine, Houston TX

Investigators